health pharma news today obesity drugs glp-1 today A major breakthrough in the fight against is about to hit pharmacy shelves across the U.S. The FDA has just approved the world's first oral GLP -1 weight-loss medication — and it World Health Leaders | FDA
Description
A written log helps your doctor adjust dosage without guesswork
Hepatic Glucagon Receptor Signaling Enhances Insulin-Stimulated Glucose Disposal in Rodents

it's about new chances and a brighter view of life

No significantly increased risk for thyroid cancer was observed for adults using a GLP-1 receptor agonist compared with those using a DPP-IV inhibitor (HR = 0.81

GLP-1 associated hair loss is unique in that the continued weight loss is a continued stressor,' said Jenni Holman, MD, FAAD, a diplomate of the American Academy of Dermatology

Expert Opin Pharmacother 2011;12:143951.ArticlePubMed 98